Status:
RECRUITING
Resorbable Magnesium Scaffolds Registry
Lead Sponsor:
Biotronik AG
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of...
Eligibility Criteria
Inclusion
- According to the IFU
Exclusion
- According to the IFU
Key Trial Info
Start Date :
November 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2030
Estimated Enrollment :
1106 Patients enrolled
Trial Details
Trial ID
NCT04679740
Start Date
November 18 2020
End Date
May 1 2030
Last Update
November 21 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairns Hospital
Cairns, Australia, 4870
2
Heart Center Segeberger Kliniken
Bad Segeberg, Germany, 23795
3
Krankenhaus Buchholz
Buchholz, Germany, 21244
4
Klinikum Westfalen, Knappschaft KH
Dortmund, Germany, 44309